Aif Management LLC

Emerging manager

SEC exempt reporting adviser (venture capital exemption).

Website: https://autismimpact.fund/
HQ: FL

AIF Management is a healthcare technology and innovation firm investing in behavioral health, mental health, autism, and complex chronic conditions. Its team includes co-founders, a managing partner, and several operating partners. Its portfolio spans autism diagnostics, ABA software, pediatric care, and therapeutics.

New fund likely raising soon

The firm's newest fund is 4 to 7 years past its first sale and no newer Form D has been filed.

01 · Says / Does

Tag	Says	Does
Stages	Not stated	Not enough dated deals
Sectors	Healthtech, Digital health, Biotech	Not enough dated deals
Regions	Not stated	Not enough dated deals

Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.

02 · Fund history

Fund	Year	Size	Status
AUTISM IMPACT FUND LP	2021	$28.31M to $32.98M (Form D and SEC adviser filing)	Follow-ons only

03 · People across funds

CHRISTOPHER MALE, MANAGING MEMBER OF THE GENERAL PARTNER OF THE ISSUER
AUTISM IMPACT FUND LP (Named on Form D)
Ashok Srinivasan, Chief Scientific Officer
AUTISM IMPACT FUND LP (Team)
Brian O’Callaghan, Co-Founder
AUTISM IMPACT FUND LP (Team)
Dan Tarman, Chief Communications Officer
AUTISM IMPACT FUND LP (Team)
Heidi Holcombe, Chief of Staff
AUTISM IMPACT FUND LP (Team)
Lauren Ingram, Principal
AUTISM IMPACT FUND LP (Team)
Nikhita Kulkarni, Senior Associate, Investments & Investor Relations
AUTISM IMPACT FUND LP (Team)
Robbie Allen, Operating Partner
AUTISM IMPACT FUND LP (Team)
Robert Sarrazin, Chief Investment Officer & Managing Partner
AUTISM IMPACT FUND LP (Team)
Taylor Gordy, Operating Partner
AUTISM IMPACT FUND LP (Team)

04 · Recent deals

No dated deals found yet.

05 · Latest from the firm

No news from the firm's website yet.

06 · Sources

Fund dates and sizes are from SEC Form D filings.

Last verified: Oct 25, 2026